DekaBank Deutsche Girozentrale’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21M | Hold |
115,130
| – | – | 0.04% | 312 |
|
|
2026
Q1 | $21.4M | Hold |
115,130
| – | – | 0.04% | 312 |
|
|
2025
Q4 | $14M | Hold |
115,130
| – | – | 0.02% | 389 |
|
|
2025
Q3 | $14.7M | Hold |
115,130
| – | – | 0.02% | 376 |
|
|
2025
Q2 | $12.2M | Sell |
115,130
-178
| -0.2% | -$19.3K | 0.02% | 408 |
|
|
2025
Q1 | $13.9M | Buy |
115,308
+178
| +0.2% | +$23.2K | 0.03% | 366 |
|
|
2024
Q4 | $13.9M | Hold |
115,130
| – | – | 0.03% | 384 |
|
|
2024
Q3 | $12.6M | Buy |
115,130
+31,283
| +37% | +$3.43M | 0.02% | 413 |
|
|
2024
Q2 | $8.91M | Sell |
83,847
-31,461
| -27% | -$3.46M | 0.02% | 472 |
|
|
2024
Q1 | $13.9M | Buy |
115,308
+23,768
| +26% | +$2.91M | 0.03% | 383 |
|
|
2023
Q4 | $11.2M | Buy |
91,540
+44,414
| +94% | +$5.54M | 0.02% | 403 |
|
|
2023
Q3 | $6.16M | Buy |
47,126
+262
| +0.6% | +$34.9K | 0.01% | 503 |
|
|
2023
Q2 | $5.82M | Sell |
46,864
-3,649
| -7% | -$491K | 0.01% | 524 |
|
|
2023
Q1 | $7.25M | Sell |
50,513
-3,097
| -6% | -$458K | 0.02% | 472 |
|
|
2022
Q4 | $8.44M | Sell |
53,610
-8,366
| -13% | -$1.23M | 0.02% | 430 |
|
|
2022
Q3 | $8.21M | Sell |
61,976
-5,575
| -8% | -$848K | 0.02% | 422 |
|
|
2022
Q2 | $10.4M | Buy |
67,551
+613
| +0.9% | +$94.4K | 0.03% | 378 |
|
|
2022
Q1 | $10.6M | Sell |
66,938
-11,522
| -15% | -$1.67M | 0.03% | 416 |
|
|
2021
Q4 | $10.3M | Buy |
78,460
+25,003
| +47% | +$3.29M | 0.03% | 412 |
|
|
2021
Q3 | $6.91M | Sell |
53,457
-36,192
| -40% | -$5.47M | 0.02% | 460 |
|
|
2021
Q2 | $15.8M | Sell |
89,649
-374
| -0.4% | -$64.8K | 0.05% | 299 |
|
|
2021
Q1 | $14.9M | Buy |
90,023
+21,307
| +31% | +$3.51M | 0.05% | 283 |
|
|
2020
Q4 | $11M | Buy |
68,716
+11,364
| +20% | +$1.69M | 0.04% | 311 |
|
|
2020
Q3 | $7.94M | Buy |
57,352
+31,828
| +125% | +$3.95M | 0.04% | 315 |
|
|
2020
Q2 | $2.78M | Sell |
25,524
-2,073
| -8% | -$229K | 0.02% | 417 |
|
|
2020
Q1 | $2.76M | Sell |
27,597
-2,358
| -8% | -$305K | 0.02% | 368 |
|
|
2019
Q4 | $4.46M | Sell |
29,955
-23,717
| -44% | -$3.23M | 0.03% | 359 |
|
|
2019
Q3 | $6.86M | Sell |
53,672
-35,617
| -40% | -$4.77M | 0.04% | 310 |
|
|
2019
Q2 | $12.4M | Buy |
89,289
+62,682
| +236% | +$8.42M | 0.06% | 292 |
|
|
2019
Q1 | $4.61M | Sell |
26,607
-2,368
| -8% | -$309K | 0.03% | 439 |
|
|
2018
Q4 | $3.55M | Buy |
28,975
+2,368
| +9% | +$351K | 0.02% | 426 |
|
|
2018
Q3 | $4.61M | Buy |
26,607
+884
| +3% | +$152K | 0.03% | 445 |
|
|
2018
Q2 | $4.51M | Sell |
25,723
-10,112
| -28% | -$1.65M | 0.03% | 421 |
|
|
2018
Q1 | $5.36M | Sell |
35,835
-13,324
| -27% | -$1.95M | 0.04% | 379 |
|
|
2017
Q4 | $7.3M | Hold |
49,159
| – | – | 0.06% | 303 |
|
|
2017
Q3 | $7.3M | Sell |
49,159
-10,398
| -17% | -$1.57M | 0.06% | 306 |
|
|
2017
Q2 | $9.32M | Sell |
59,557
-126
| -0.2% | -$19.3K | 0.07% | 264 |
|
|
2017
Q1 | $8.72M | Buy |
59,683
+4,527
| +8% | +$590K | 0.08% | 240 |
|
|
2016
Q4 | $5.97M | Buy |
55,156
+662
| +1% | +$73.7K | 0.06% | 272 |
|
|
2016
Q3 | $6.7M | Buy |
54,494
+15,858
| +41% | +$2.14M | 0.07% | 263 |
|
|
2016
Q2 | $5.43M | Buy |
38,636
+320
| +0.8% | +$47.2K | 0.06% | 287 |
|
|
2016
Q1 | $4.76M | Sell |
38,316
-3,150
| -8% | -$392K | 0.06% | 317 |
|
|
2015
Q4 | $5.93M | Buy |
41,466
+390
| +0.9% | +$54K | 0.07% | 277 |
|
|
2015
Q3 | $5.46M | Buy |
41,076
+2,576
| +7% | +$444K | 0.07% | 287 |
|
|
2015
Q2 | $6.78M | Buy |
38,500
+870
| +2% | +$156K | 0.08% | 240 |
|
|
2015
Q1 | $6.5M | Sell |
37,630
-3,100
| -8% | -$532K | 0.08% | 255 |
|
|
2014
Q4 | $6.64M | Buy |
40,730
+3,330
| +9% | +$553K | 0.08% | 248 |
|
|
2014
Q3 | $6M | Buy |
37,400
+830
| +2% | +$128K | 0.08% | 238 |
|
|
2014
Q2 | $5.38M | Buy |
36,570
+250
| +0.7% | +$34.7K | 0.08% | 257 |
|
|
2014
Q1 | $5.04M | Buy |
36,320
+3,170
| +10% | +$477K | 0.08% | 247 |
|
|
2013
Q4 | $4.1M | Sell |
33,150
-4,004
| -11% | -$414K | 0.07% | 230 |
|
|
2013
Q3 | $3.31M | Buy |
37,154
+2,450
| +7% | +$198K | 0.06% | 241 |
|
|
2013
Q2 | $2.38M | Buy |
+34,704
| New | +$2.12M | 0.05% | 263 |
|
Other funds holding JAZZ
BTW
PCM
ACM
DekaBank Deutsche Girozentrale's JAZZ Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 115,130 shares worth $21M. The position accounts for 0.04% of the portfolio, ranked #312.
DekaBank Deutsche Girozentrale first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.4M in Q1 2026. 304 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- DekaBank Deutsche Girozentrale held 115,130 shares of Jazz Pharmaceuticals worth $21M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
- Jazz Pharmaceuticals made up 0.04% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #312 holding.
- DekaBank Deutsche Girozentrale first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- DekaBank Deutsche Girozentrale's Jazz Pharmaceuticals position peaked at $21.4M in Q1 2026.
- 304 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.